82
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Diagnosis of myocardial infarction using the new universal definition: Is it enough for risk stratification and guiding decision for revascularization?

, , , , , , , & show all
Pages 130-137 | Received 10 Aug 2010, Accepted 19 Sep 2010, Published online: 18 Oct 2010

References

  • Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, . ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction). J Am Coll Cardiol. 2007;50:e1–157.
  • Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, . The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28:1598–660.
  • Apple FS, Falahati A, Paulsen PR, Miller EA, Sharkey SW. Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I. Clin Chem. 1997;43:2047–51.
  • Alpert JS, Thygesen K, Antman E, Bassand JP; on behalf of the Joint ESC/ACC Committee. Myocardial Infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol. 2000;36:959–69.
  • Thygesen K, Alpert JS, White HD; on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007;27:2173–95.
  • Newby LK, Christenson RH, Ohman EM, Armstrong PW, Thompson TD, Lee KL, . Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. Circulation 1998;98:1853–9.
  • Ottani F, Galani M, Nicolini FA, Ferrini D, Pozzati A, Di Pasquale G, . Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J. 2000;140:917–27.
  • Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA. The prognostic value of troponin in patients with non–ST elevation acute coronary syndromes: a meta-analysis, J Am Coll Cardiol. 2001;38:478–85.
  • Fragmin and fast revascularisation during instability in coronary artery disease (FRISC II) Investigators, Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet 1999; 354:708–15.
  • Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, . Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879–87.
  • Carruthers KF, Dabbous OH, Flather MD, Starkey I, Jacob A, Macleod D, . Contemporary management of acute coronary syndromes: does the practice match the evidence? The global registry of acute coronary events (GRACE). Heart 2005;91:290–8.
  • de Araújo Gonçalves P, Ferreira J, Aguiar C, Seabra-Gomes R. TIMI, PURSUIT and GRACE risk scores: Sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J. 2005;26:865–72.
  • Panteghini M, Gerhardt W, Apple FS, Dati F, Ravkilde J, Wu AH. Quality specifications for cardiac troponin assays. Clin Chem Lab Med. 2001;39:174–8.
  • Report of the Joint International Society and Federation of Cardiology/world Heath Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979;59:607–9.
  • Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, van de Werf F, . A validated prediction model for all forms of acute coronary syndrome: Estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004;291:2727–33.
  • Meier MA, Al-Badr WH, Cooper JV, Kline-Rogers EM, Smith DE, Eagle KA, . The new definition of myocardial infarction: diagnostic and prognostic implications in patients with acute coronary syndromes. Arch Intern Med. 2002;162:1585–9.
  • Newby LK, Goldmann BU, Ohman EM. Troponin: An important prognostic marker and risk-stratification tool in non-ST segment elevation acute coronary syndromes. J Am Coll Cardiol. 2003;41:31S–6S.
  • Goodman SG, Steg PG, Eagle KA, Fox KA, López-Sendón J, Montalescot G, . The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: Lessons from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2006;151:654–60.
  • Antman EM, Grudzien C, Mitchell RN, Sacks DB. Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T. Am Heart J. 1997;133:596–8.
  • Kohrer K, Lang HR, Ecker M. Experience with cardiac troponin T in difficult cases. Eur Heart J. 1998;19(Suppl. N):N38–41.
  • Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, . Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000;102:1014–9.
  • Kaul P, Fu Y, Chang WC, Harrington RA, Wagner GS, Goodman SG, . Prognostic value of ST segment depression in acute coronary syndromes: Insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network. J Am Coll Cardiol. 2001;38:64–71.
  • Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, . Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE quality improvement initiative. JAMA 2004;292:2096–104.
  • Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, . Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344;1879–87.
  • Diderholm E, Andren B, Frostfeldt G, Genberg M, Jernberg T, Lagerqvist B, . The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: The FRISC II invasive troponin T electrocardiogram substudy. Am Heart J. 2002;143:760–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.